Inovio Pharmaceuticals, Inc.INONASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank50
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-86.82M
↑ 38% vs avg
Percentile
P50
Within normal range
Streak
4 yr
Consecutive growthExpanding
Average
$-140.11M
Historical baseline
PeriodValueYoY Change
2025$-86.82M+22.8%
2024$-112.40M+21.9%
2023$-143.94M+46.2%
2022$-267.57M+11.2%
2021$-301.22M-142.8%
2020$-124.08M-11.7%
2019$-111.11M-18.1%
2018$-94.09M-12.5%
2017$-83.64M-9.7%
2016$-76.24M-